Kizoo Technology Capital

Kizoo Technology Capital is a venture capital firm specializing in rejuvenation biotechnology, investing in companies that develop therapies to prevent and reverse age-related diseases. The firm targets the fundamental biological processes of aging, supporting technologies that address cellular degradation like molecular waste accumulation, tissue calcification, and stem cell dysfunction.

Established around 1999, the firm's focus on longevity stems from the vision of co-founder Michael Greve, also known for founding the Forever Healthy Foundation. This deep-seated commitment drives Kizoo’s approach to identifying and nurturing early-stage companies pursuing advanced solutions for extending human healthspan.

Kizoo actively supports innovative biotech ventures focused on repairing age-related damage and enhancing human health. Providing strategic financing and mentorship, the firm aims to accelerate pioneering therapy development. Its ultimate vision is to significantly contribute to a future where scientific breakthroughs deliver widely accessible rejuvenation technologies, thereby extending healthy human lifespans globally.